{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:15:01Z","timestamp":1788387301015,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/mnm.0b013e328334fc14","type":"journal-article","created":{"date-parts":[[2010,1,30]],"date-time":"2010-01-30T02:27:16Z","timestamp":1264818436000},"page":"232-238","source":"Crossref","is-referenced-by-count":46,"title":["False-positive F-18 FDG uptake in PET\/CT studies in pediatric patients with abdominal Burkitt's lymphoma"],"prefix":"10.1097","volume":"31","author":[{"given":"Raef","family":"Riad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Zamzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein M.","family":"Abdel-Dayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210212","first-page":"413","article-title":"Manual of pediatric hematology and oncology. 3rd ed","author":"Lanzkowski","year":"1999"},{"key":"R2-9-20210212","first-page":"119","article-title":"Cancer in children. Clinical management. 4th ed","author":"B\u00fcy\u00fckpamuk\u00e7u","year":"1998"},{"key":"R3-9-20210212","first-page":"545","article-title":"Principles & practice of pediatric oncology. 5th ed","author":"Michael","year":"2006"},{"key":"R4-9-20210212","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"R5-9-20210212","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"R6-9-20210212","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"key":"R7-9-20210212","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's lymphoma classification project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Onc"},{"key":"R8-9-20210212","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1200\/JCO.1983.1.11.682","article-title":"Extralymphatic involvement in diffuse non-Hodgkin's lymphoma","volume":"1","author":"Paryani","year":"1983","journal-title":"J Clin Oncol"},{"key":"R9-9-20210212","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"key":"R10-9-20210212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/1097-0142(19800701)46:1<215::AID-CNCR2820460136>3.0.CO;2-6","article-title":"Gastrointestinal involvement in non-Hodgkin's lymphoma","volume":"46","author":"Hermann","year":"2006","journal-title":"Cancer Cytopathol"},{"key":"R11-9-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.1989.tb01585.x","article-title":"Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease","volume":"15","author":"Shepherd","year":"2007","journal-title":"Histopathology"},{"key":"R12-9-20210212","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/1097-0142(197805)41:5<1984::AID-CNCR2820410544>3.0.CO;2-8","article-title":"Diffuse histiocytic lymphoma involving the gastrointestinal tract","volume":"41","author":"Hande","year":"2006","journal-title":"Cancer"},{"key":"R13-9-20210212","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1440-1746.2005.04114.x","article-title":"Gastrointestinal: Burkitt's lymphoma","volume":"20","author":"Liou","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R14-9-20210212","first-page":"137","article-title":"Cancer in children. Clinical management. 4th ed","author":"Oberlin","year":"1998"},{"key":"R16-9-20210212","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0031-3955(16)38086-5","article-title":"Non-Hodgkin's lymphoma: biologic classification and implication for therapy","volume":"38","author":"Kutzberg","year":"1991","journal-title":"Pediatr Clin North Am"},{"key":"R17-9-20210212","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/JCO.1986.4.2.147","article-title":"Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)","volume":"4","author":"Coiffier","year":"1986","journal-title":"J Clin Oncol"},{"key":"R18-9-20210212","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/cbr.2008.0519","article-title":"18F-FDG Pet in pediatric lymphomas: a comparison with conventional imaging","volume":"23","author":"Lopci","year":"2008","journal-title":"Cancer Biotherapy Radiopharm"},{"key":"R19-9-20210212","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00247-003-1114-3","article-title":"PET imaging in pediatric Hodgkin's lymphoma","volume":"34","author":"Hudson","year":"2004","journal-title":"Pediatric Radiol"},{"key":"R20-9-20210212","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/10428190601078118","article-title":"PET and PET\/CT for response evaluation in lymphoma: current practice and developments","volume":"48","author":"Brepoels","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R21-9-20210212","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","article-title":"Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18F) FDG after first line chemotherapy in non Hodgkin's lymphoma: is (18F) FDG-PET a valid alternative to conventional diagnostic methods?","volume":"19","author":"Spaepen","year":"2001","journal-title":"J Clin Oncology"},{"issue":"1","key":"R22-9-20210212","first-page":"177","article-title":"Utilization of 18F-FDG PET\/CT in pediatric lymphoma management","volume":"49","author":"Moinuddin","year":"2008","journal-title":"J Nucl Med"},{"issue":"1","key":"R23-9-20210212","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/s00259-003-1167-4","article-title":"PET and restaging of malignant lymphoma including residual masses and relapse","volume":"30","author":"Reske","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R24-9-20210212","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0221-0363(08)89015-4","article-title":"Imaging and PET-CT of adult and childhood lymphoma","volume":"89","author":"Montravers","year":"2008","journal-title":"J Radiol"},{"key":"R25-9-20210212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiographics.19.1.g99ja0761","article-title":"Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants","volume":"19","author":"Shreve","year":"1999","journal-title":"Radiographics"},{"key":"R26-9-20210212","first-page":"1412","article-title":"Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes","volume":"42","author":"Zhuang","year":"2001","journal-title":"J Nucl Med"},{"key":"R27-9-20210212","first-page":"1972","article-title":"Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography","volume":"33","author":"Kubota","year":"1992","journal-title":"J Nucl Med"},{"key":"R28-9-20210212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00277-006-0167-4","article-title":"Borght: unsuspected FDG\u2013PET findings in the follow-up of patients with lymphoma","volume":"86","author":"Sonet","year":"2007","journal-title":"Ann Hematol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0b013e328334fc14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:58Z","timestamp":1786040338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-201003000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328334fc14","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}